Promoter declares no new encumbrances in FY26

1 min read     Updated on 13 Jun 2026, 06:56 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Promoter Chandrakumar Laxminarayan Rathi disclosed no new encumbrances for FY26 under SEBI regulations. The filing lists five PACs, including Advenza Global Limited and Atharva Green Ecotech LLP.

powered bylight_fuzz_icon
42859578

*this image is generated using AI for illustrative purposes only.

Chandrakumar Laxminarayan Rathi, a promoter of Advanced Enzyme Technologies Limited , has declared that he and Persons Acting in Concert (PAC) have not created any new encumbrances during the financial year. The disclosure, submitted to the stock exchanges and the company's Audit Committee, confirms that no direct or indirect charges have been made other than those already disclosed.

The declaration was made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to disclose any encumbrance on shares held by them or PACs to ensure transparency for shareholders.

The filing, dated April 01, 2026, identifies the following entities as part of the Promoter Group acting in concert with Rathi:

Name(s) of the person and Persons Acting in Concert (PAC) with the person Whether the person belongs to Promoter/ Promoter group
Savita Chandrakumar Rathi Promoter Group
Radhika Ashish Pujara Promoter Group
Piyush Chandrakumar Rathi Promoter Group
Advenza Global Limited (formerly known as Advanced Vital Enzymes Private Limited) Promoter Group
Atharva Green Ecotech LLP Promoter Group

The document was digitally signed by Chandrakumar Laxminarayan Rathi on April 07, 2026, and addressed to BSE Limited, National Stock Exchange of India Limited, and the Audit Committee of Advanced Enzyme Technologies Limited.

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-0.43%+0.08%-0.66%+18.52%+13.00%-10.72%

What impact will this clean encumbrance status have on investor confidence and share liquidity?

Could this disclosure signal potential future strategic investments or acquisitions by the promoter group?

How might this transparency influence the company's credit rating or borrowing costs?

Rajshree Patel ceases as Independent Director at Advanced Enzyme Technologies

0 min read     Updated on 12 Jun 2026, 05:14 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Rajshree Patel ceased to be an Independent Director at Advanced Enzyme Technologies Ltd on June 11, 2026, upon completing her second consecutive term. The cessation was effective from the end of business hours on the same day.

powered bylight_fuzz_icon
42767050

*this image is generated using AI for illustrative purposes only.

Rajshree Patel ceased to be an Independent Director at Advanced Enzyme Technologies Ltd on June 11, 2026, upon the completion of her second consecutive term. The change in the board composition was effective from the end of business hours on June 11, 2026.

The company informed the stock exchanges regarding the cessation of the director pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. The disclosure was also made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated July 11, 2023, as updated on January 30, 2026.

Details of Cessation

The following table outlines the specific details regarding the change in directorship:

Particulars Details
Name of Director Ms. Rajshree Patel (DIN – 08761022)
Reason for Cessation Completion of second term as an Independent Director
Date of Cessation June 11, 2026
Effective Time End of business hours

The filing was submitted by Sanjay Basantani, Company Secretary and Head – Legal, on behalf of Advanced Enzyme Technologies Ltd .

Historical Stock Returns for Advanced Enzyme Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-0.43%+0.08%-0.66%+18.52%+13.00%-10.72%

Who will be appointed to replace Rajshree Patel, and how will their expertise align with Advanced Enzyme Technologies' strategic goals?

How will the change in board composition impact the company's governance policies and committee structures?

What is the timeline for announcing the new independent director, and will the market react positively to the appointment?

More News on Advanced Enzyme Tech

1 Year Returns:+13.00%